Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jim Baumgardt
AddedFeb 15, 2024
UpdatedMay 1, 2026
Jim Baumgardt

Jim Baumgardt

Board Member, NeoChord

Jim Baumgardt's Career

NeoChord
NeoChord

St. Louis Park, MN, US

Board Member· Board
Nico
Nico

Indianapolis, IN, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jim Baumgardt's Career

NeoChord
NeoChord
Seed$89.9M242009St. Louis Park, MN, US
Board Member· Board

Leadership at NeoChord

Nicole J WalkerNicole J WalkerBoard Member
David ChungDavid ChungCEO
Casey TanseyCasey TanseyBoard Member
Mudit K JainMudit K JainBoard Member
John SeabergJohn SeabergFounder
Andrew ElbardissiAndrew ElbardissiBoard Member

Similar to NeoChord

Cardiac DimensionsCardiac DimensionsKirkland, WA, USMedical Devicesest. 2001Cardiac DimensionsKirkland, WA, US · est. 2001

US-based Cardiac Dimensions develops global medical devices for heart failure and mitral valve treatment.

Public · $209.7M62
Nectero MedicalNectero MedicalDover, DE, USMedical Devicesest. 2017Nectero MedicalDover, DE, US · est. 2017

Nectero Medical: Innovating treatments to stabilize and prevent abdominal aortic aneurysms.

Series C · $19.5M14
NeocisNeocisMiami, FL, USSurgical Robotsest. 2009NeocisMiami, FL, US · est. 2009

Neocis: Revolutionizing dental surgery with advanced, robot-assisted implant technology.

Series D · $183.1M175
NicoNicoIndianapolis, IN, USMedical Devicesest. 2007NicoIndianapolis, IN, US · est. 2007

NICO Corp: Global provider of innovative medical devices for minimally invasive neuro and spinal surgeries.

Series B · $68.1M104
Nico
Nico
Series B$68.1M1042007Indianapolis, IN, US
Board Member· Board

Leadership at Nico

Ryan KitchellRyan KitchellBoard Member
Eric TimkoEric TimkoBoard Member
Kyle SalyersKyle SalyersBoard Member
Niles NoblittNiles NoblittBoard Member
J. Carter McNabbJ. Carter McNabbBoard Member
Joseph MarkJoseph MarkBoard Member

Similar to Nico

NevroNevroRedwood City, CA, USMedical Devicesest. 2006NevroRedwood City, CA, US · est. 2006

Nevro Corp., a global medical device company, specializes in spinal cord stimulation systems to treat chronic pain.

Public · $555.8M1.1k
Neuro KineticsNeuro KineticsPittsburgh, PA, USMedical Instrumentsest. 1984Neuro KineticsPittsburgh, PA, US · est. 1984

Neuro Kinetics Inc: A leading manufacturer of medical and surgical instruments since 2002.

Angel · $1.3M32
NeuroBionicsNeuroBionicsSeattle, WA, USMedical DevicesNeuroBionicsSeattle, WA, US

Developing medical devices for neurological disorders.

Series A · $6M6
Niche BiomedicalNiche BiomedicalLos Angeles, CA, USMedical Devicesest. 2016Niche BiomedicalLos Angeles, CA, US · est. 2016

Niche Biomedical: Innovating neuromodulation devices for enhanced human health.

Pre-Seed · $1.4M15

Jim Baumgardt's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Jim Baumgardt

Bob BaumgartnerBob BaumgartnerBoard Member · Bio-TechneEric ThépautEric ThépautBoard Member · Boston ScientificJames QuandtJames QuandtBoard Member · BrainVance R. BrownVance R. BrownBoard Member · EndoChoice HoldingsJustin BatemanJustin BatemanBoard Member · MultiplanSimon StertzerSimon StertzerBoard Member · BioCardia